Atlas Trials

Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs

Clinical trial NCT02592707 · TERMINATED

Trial details

NCT number
NCT02592707
Sponsor
Ipsen
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2017-03-06
Primary completion
2022-02-22
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.